» Articles » PMID: 30793766

Ebp1 P48 Promotes Oncogenic Activities in Human Colon Cancer Cells Through Regulation of TIF-90-mediated Ribosomal RNA Synthesis

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2019 Feb 23
PMID 30793766
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The ErbB3-binding protein 1 (Ebp1) has been reported as either an oncogenic regulator or a tumor suppressor in a variety of cancers. Here, we show that Ebp1 p48, a predominant expression isoform, is highly expressed in the majority of human colon tumor cells compared with normal adjacent tissues and its expression is required for the oncogenic activities of these cells. Depletion of Ebp1 expression in primary colon cancer cells inhibits cell proliferation, colony forming, and invasion in vitro as well as tumor formation in vivo and enhances cell sensitivity to irradiation. We further demonstrated that Ebp1 interacts with TIF-90, a splice variant of transcription initiation factor IA (TIF-IA) of the RNA polymerase I complex, allowing for regulation of ribosomal RNA (rRNA) synthesis and oncogenesis in human colon cancer cells. Moreover, Ebp1 expression is essential for Akt protected TIF-90 stability by preventing TIF-90's ubiquitination by Mdm2 and hence, its proteasomal degradation. The results of the present study support a mechanism of underlying oncogenic activities by means of Ebp1 through regulation of TIF-90-mediated rRNA synthesis and suggest the potential therapeutic treatment of colon cancer by targeting Ebp1 and its signaling.

Citing Articles

Knockdown of EBP1 promotes doxorubicin-induced apoptosis in renal clear cell carcinoma cells through activation of the p38/HIF-1α pathway.

Ma L, Huo J, Cao S, Yue Y, Li X, Tian S Oncol Lett. 2025; 29(4):172.

PMID: 39968014 PMC: 11834144. DOI: 10.3892/ol.2025.14918.


Proliferation-associated 2G4 P48 is stabilized by malignant T-cell amplified sequence 1 and promotes the proliferation of head and neck squamous cell carcinoma.

Sun L, Xing G, Wang W, Ma X, Bu X J Dent Sci. 2023; 18(4):1588-1597.

PMID: 37799877 PMC: 10548002. DOI: 10.1016/j.jds.2023.02.020.


PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.

Sun S, Liu Y, Zhou M, Wen J, Xue L, Han S Cell Biosci. 2022; 12(1):55.

PMID: 35526051 PMC: 9080163. DOI: 10.1186/s13578-022-00788-5.


Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism.

Hoang D, Morales C, Rodriguez I, Valerio M, Guo J, Chen M Cancers (Basel). 2022; 14(6).

PMID: 35326597 PMC: 8946614. DOI: 10.3390/cancers14061446.


ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway.

Bao Y, Cui J, Yue Y, Cao S, Li X, Liu L Cancer Cell Int. 2022; 22(1):44.

PMID: 35093077 PMC: 8800265. DOI: 10.1186/s12935-022-02473-6.